Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Anti-Viral Drugs market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Anti-Viral Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Anti-Viral Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Roche
Schering-Plough
Cipla
AstraZeneca
Bristol-Myers-Squibb
Novartis
Gilead Sciences
Abbott
Gilead
GlaxoSmithKline & Co
By Type:
Hepatitis-C Antivirals
HIV Antivirals
Herpes Antivirals
Hepatitis-B Antivirals
Influenza Antivirals
Others (Pneumonia, Flu, etc.)
By End-User:
Hospitals
Clinics
Ambulatory Surgical Centers
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Anti-Viral Drugs Market
-
1.3 Market Segment by Type
1.3.1 Japan Anti-Viral Drugs Market Size and Growth Rate of Hepatitis-C Antivirals from 2014 to 2026
1.3.2 Japan Anti-Viral Drugs Market Size and Growth Rate of HIV Antivirals from 2014 to 2026
1.3.3 Japan Anti-Viral Drugs Market Size and Growth Rate of Herpes Antivirals from 2014 to 2026
1.3.4 Japan Anti-Viral Drugs Market Size and Growth Rate of Hepatitis-B Antivirals from 2014 to 2026
1.3.5 Japan Anti-Viral Drugs Market Size and Growth Rate of Influenza Antivirals from 2014 to 2026
1.3.6 Japan Anti-Viral Drugs Market Size and Growth Rate of Others (Pneumonia, Flu, etc.) from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Anti-Viral Drugs Market Size and Growth Rate of Hospitals from 2014 to 2026
1.4.2 Japan Anti-Viral Drugs Market Size and Growth Rate of Clinics from 2014 to 2026
1.4.3 Japan Anti-Viral Drugs Market Size and Growth Rate of Ambulatory Surgical Centers from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Anti-Viral Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Anti-Viral Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Anti-Viral Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Anti-Viral Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Anti-Viral Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Anti-Viral Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Anti-Viral Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Anti-Viral Drugs Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Anti-Viral Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Anti-Viral Drugs by Major Types
3.4.1 Market Size and Growth Rate of Hepatitis-C Antivirals
3.4.2 Market Size and Growth Rate of HIV Antivirals
3.4.3 Market Size and Growth Rate of Herpes Antivirals
3.4.4 Market Size and Growth Rate of Hepatitis-B Antivirals
3.4.5 Market Size and Growth Rate of Influenza Antivirals
3.4.6 Market Size and Growth Rate of Others (Pneumonia, Flu, etc.)
4 Segmentation of Anti-Viral Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Anti-Viral Drugs by Major End-Users
4.4.1 Market Size and Growth Rate of Anti-Viral Drugs in Hospitals
4.4.2 Market Size and Growth Rate of Anti-Viral Drugs in Clinics
4.4.3 Market Size and Growth Rate of Anti-Viral Drugs in Ambulatory Surgical Centers
5 Market Analysis by Regions
-
5.1 Japan Anti-Viral Drugs Production Analysis by Regions
-
5.2 Japan Anti-Viral Drugs Consumption Analysis by Regions
6 Hokkaido Anti-Viral Drugs Landscape Analysis
-
6.1 Hokkaido Anti-Viral Drugs Landscape Analysis by Major Types
-
6.2 Hokkaido Anti-Viral Drugs Landscape Analysis by Major End-Users
7 Tohoku Anti-Viral Drugs Landscape Analysis
-
7.1 Tohoku Anti-Viral Drugs Landscape Analysis by Major Types
-
7.2 Tohoku Anti-Viral Drugs Landscape Analysis by Major End-Users
8 Kanto Anti-Viral Drugs Landscape Analysis
-
8.1 Kanto Anti-Viral Drugs Landscape Analysis by Major Types
-
8.2 Kanto Anti-Viral Drugs Landscape Analysis by Major End-Users
9 Chubu Anti-Viral Drugs Landscape Analysis
-
9.1 Chubu Anti-Viral Drugs Landscape Analysis by Major Types
-
9.2 Chubu Anti-Viral Drugs Landscape Analysis by Major End-Users
10 Kinki Anti-Viral Drugs Landscape Analysis
-
10.1 Kinki Anti-Viral Drugs Landscape Analysis by Major Types
-
10.2 Kinki Anti-Viral Drugs Landscape Analysis by Major End-Users
11 Chugoku Anti-Viral Drugs Landscape Analysis
-
11.1 Chugoku Anti-Viral Drugs Landscape Analysis by Major Types
-
11.2 Chugoku Anti-Viral Drugs Landscape Analysis by Major End-Users
12 Shikoku Anti-Viral Drugs Landscape Analysis
-
12.1 Shikoku Anti-Viral Drugs Landscape Analysis by Major Types
-
12.2 Shikoku Anti-Viral Drugs Landscape Analysis by Major End-Users
13 Kyushu Anti-Viral Drugs Landscape Analysis
-
13.1 Kyushu Anti-Viral Drugs Landscape Analysis by Major Types
-
13.2 Kyushu Anti-Viral Drugs Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Roche
14.1.1 Roche Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Schering-Plough
14.2.1 Schering-Plough Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 Cipla
14.3.1 Cipla Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 AstraZeneca
14.4.1 AstraZeneca Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 Bristol-Myers-Squibb
14.5.1 Bristol-Myers-Squibb Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 Novartis
14.6.1 Novartis Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Gilead Sciences
14.7.1 Gilead Sciences Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 Abbott
14.8.1 Abbott Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 Gilead
14.9.1 Gilead Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 GlaxoSmithKline & Co
14.10.1 GlaxoSmithKline & Co Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
The List of Tables and Figures (Totals 139 Figures and 152 Tables)
Figure Japan Anti-Viral Drugs Market Size and Growth Rate of Hepatitis-C Antivirals from 2014 to 2026
Figure Japan Anti-Viral Drugs Market Size and Growth Rate of HIV Antivirals from 2014 to 2026
Figure Japan Anti-Viral Drugs Market Size and Growth Rate of Herpes Antivirals from 2014 to 2026
Figure Japan Anti-Viral Drugs Market Size and Growth Rate of Hepatitis-B Antivirals from 2014 to 2026
Figure Japan Anti-Viral Drugs Market Size and Growth Rate of Influenza Antivirals from 2014 to 2026
Figure Japan Anti-Viral Drugs Market Size and Growth Rate of Others (Pneumonia, Flu, etc.) from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Anti-Viral Drugs Market Size and Growth Rate of Hospitals from 2014 to 2026
Figure Japan Anti-Viral Drugs Market Size and Growth Rate of Clinics from 2014 to 2026
Figure Japan Anti-Viral Drugs Market Size and Growth Rate of Ambulatory Surgical Centers from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Anti-Viral Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Anti-Viral Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Anti-Viral Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Anti-Viral Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Anti-Viral Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Anti-Viral Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Anti-Viral Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Anti-Viral Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Anti-Viral Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Anti-Viral Drugs
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Anti-Viral Drugs by Different Types from 2014 to 2026
-
Table Consumption Share of Anti-Viral Drugs by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Hepatitis-C Antivirals
Figure Market Size and Growth Rate of HIV Antivirals
Figure Market Size and Growth Rate of Herpes Antivirals
Figure Market Size and Growth Rate of Hepatitis-B Antivirals
Figure Market Size and Growth Rate of Influenza Antivirals
Figure Market Size and Growth Rate of Others (Pneumonia, Flu, etc.)
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Anti-Viral Drugs by Different End-Users from 2014 to 2026
-
Table Consumption Share of Anti-Viral Drugs by Different End-Users from 2014 to 2026
Figure Japan Anti-Viral Drugs Market Size and Growth Rate of Hospitals from 2014 to 2026
Figure Japan Anti-Viral Drugs Market Size and Growth Rate of Clinics from 2014 to 2026
Figure Japan Anti-Viral Drugs Market Size and Growth Rate of Ambulatory Surgical Centers from 2014 to 2026
-
Table Japan Anti-Viral Drugs Production by Regions
-
Table Japan Anti-Viral Drugs Production Share by Regions
-
Figure Japan Anti-Viral Drugs Production Share by Regions in 2014
-
Figure Japan Anti-Viral Drugs Production Share by Regions in 2018
-
Figure Japan Anti-Viral Drugs Production Share by Regions in 2026
-
Table Japan Anti-Viral Drugs Consumption by Regions
-
Table Japan Anti-Viral Drugs Consumption Share by Regions
-
Figure Japan Anti-Viral Drugs Consumption Share by Regions in 2014
-
Figure Japan Anti-Viral Drugs Consumption Share by Regions in 2018
-
Figure Japan Anti-Viral Drugs Consumption Share by Regions in 2026
-
Table Hokkaido Anti-Viral Drugs Consumption by Types from 2014 to 2026
-
Table Hokkaido Anti-Viral Drugs Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Anti-Viral Drugs Consumption Share by Types in 2014
-
Figure Hokkaido Anti-Viral Drugs Consumption Share by Types in 2018
-
Figure Hokkaido Anti-Viral Drugs Consumption Share by Types in 2026
-
Table Hokkaido Anti-Viral Drugs Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Anti-Viral Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Anti-Viral Drugs Consumption Share by End-Users in 2014
-
Figure Hokkaido Anti-Viral Drugs Consumption Share by End-Users in 2018
-
Figure Hokkaido Anti-Viral Drugs Consumption Share by End-Users in 2026
-
Table Tohoku Anti-Viral Drugs Consumption by Types from 2014 to 2026
-
Table Tohoku Anti-Viral Drugs Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Anti-Viral Drugs Consumption Share by Types in 2014
-
Figure Tohoku Anti-Viral Drugs Consumption Share by Types in 2018
-
Figure Tohoku Anti-Viral Drugs Consumption Share by Types in 2026
-
Table Tohoku Anti-Viral Drugs Consumption by End-Users from 2014 to 2026
-
Table Tohoku Anti-Viral Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Anti-Viral Drugs Consumption Share by End-Users in 2014
-
Figure Tohoku Anti-Viral Drugs Consumption Share by End-Users in 2018
-
Figure Tohoku Anti-Viral Drugs Consumption Share by End-Users in 2026
-
Table Kanto Anti-Viral Drugs Consumption by Types from 2014 to 2026
-
Table Kanto Anti-Viral Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kanto Anti-Viral Drugs Consumption Share by Types in 2014
-
Figure Kanto Anti-Viral Drugs Consumption Share by Types in 2018
-
Figure Kanto Anti-Viral Drugs Consumption Share by Types in 2026
-
Table Kanto Anti-Viral Drugs Consumption by End-Users from 2014 to 2026
-
Table Kanto Anti-Viral Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Anti-Viral Drugs Consumption Share by End-Users in 2014
-
Figure Kanto Anti-Viral Drugs Consumption Share by End-Users in 2018
-
Figure Kanto Anti-Viral Drugs Consumption Share by End-Users in 2026
-
Table Chubu Anti-Viral Drugs Consumption by Types from 2014 to 2026
-
Table Chubu Anti-Viral Drugs Consumption Share by Types from 2014 to 2026
-
Figure Chubu Anti-Viral Drugs Consumption Share by Types in 2014
-
Figure Chubu Anti-Viral Drugs Consumption Share by Types in 2018
-
Figure Chubu Anti-Viral Drugs Consumption Share by Types in 2026
-
Table Chubu Anti-Viral Drugs Consumption by End-Users from 2014 to 2026
-
Table Chubu Anti-Viral Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Anti-Viral Drugs Consumption Share by End-Users in 2014
-
Figure Chubu Anti-Viral Drugs Consumption Share by End-Users in 2018
-
Figure Chubu Anti-Viral Drugs Consumption Share by End-Users in 2026
-
Table Kinki Anti-Viral Drugs Consumption by Types from 2014 to 2026
-
Table Kinki Anti-Viral Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kinki Anti-Viral Drugs Consumption Share by Types in 2014
-
Figure Kinki Anti-Viral Drugs Consumption Share by Types in 2018
-
Figure Kinki Anti-Viral Drugs Consumption Share by Types in 2026
-
Table Kinki Anti-Viral Drugs Consumption by End-Users from 2014 to 2026
-
Table Kinki Anti-Viral Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Anti-Viral Drugs Consumption Share by End-Users in 2014
-
Figure Kinki Anti-Viral Drugs Consumption Share by End-Users in 2018
-
Figure Kinki Anti-Viral Drugs Consumption Share by End-Users in 2026
-
Table Chugoku Anti-Viral Drugs Consumption by Types from 2014 to 2026
-
Table Chugoku Anti-Viral Drugs Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Anti-Viral Drugs Consumption Share by Types in 2014
-
Figure Chugoku Anti-Viral Drugs Consumption Share by Types in 2018
-
Figure Chugoku Anti-Viral Drugs Consumption Share by Types in 2026
-
Table Chugoku Anti-Viral Drugs Consumption by End-Users from 2014 to 2026
-
Table Chugoku Anti-Viral Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Anti-Viral Drugs Consumption Share by End-Users in 2014
-
Figure Chugoku Anti-Viral Drugs Consumption Share by End-Users in 2018
-
Figure Chugoku Anti-Viral Drugs Consumption Share by End-Users in 2026
-
Table Shikoku Anti-Viral Drugs Consumption by Types from 2014 to 2026
-
Table Shikoku Anti-Viral Drugs Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Anti-Viral Drugs Consumption Share by Types in 2014
-
Figure Shikoku Anti-Viral Drugs Consumption Share by Types in 2018
-
Figure Shikoku Anti-Viral Drugs Consumption Share by Types in 2026
-
Table Shikoku Anti-Viral Drugs Consumption by End-Users from 2014 to 2026
-
Table Shikoku Anti-Viral Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Anti-Viral Drugs Consumption Share by End-Users in 2014
-
Figure Shikoku Anti-Viral Drugs Consumption Share by End-Users in 2018
-
Figure Shikoku Anti-Viral Drugs Consumption Share by End-Users in 2026
-
Table Kyushu Anti-Viral Drugs Consumption by Types from 2014 to 2026
-
Table Kyushu Anti-Viral Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Anti-Viral Drugs Consumption Share by Types in 2014
-
Figure Kyushu Anti-Viral Drugs Consumption Share by Types in 2018
-
Figure Kyushu Anti-Viral Drugs Consumption Share by Types in 2026
-
Table Kyushu Anti-Viral Drugs Consumption by End-Users from 2014 to 2026
-
Table Kyushu Anti-Viral Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Anti-Viral Drugs Consumption Share by End-Users in 2014
-
Figure Kyushu Anti-Viral Drugs Consumption Share by End-Users in 2018
-
Figure Kyushu Anti-Viral Drugs Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Roche
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
Figure Sales and Growth Rate Analysis of Roche
Figure Revenue and Market Share Analysis of Roche
Table Product and Service Introduction of Roche
Table Company Profile and Development Status of Schering-Plough
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Schering-Plough
Figure Sales and Growth Rate Analysis of Schering-Plough
Figure Revenue and Market Share Analysis of Schering-Plough
Table Product and Service Introduction of Schering-Plough
Table Company Profile and Development Status of Cipla
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cipla
Figure Sales and Growth Rate Analysis of Cipla
Figure Revenue and Market Share Analysis of Cipla
Table Product and Service Introduction of Cipla
Table Company Profile and Development Status of AstraZeneca
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
Figure Sales and Growth Rate Analysis of AstraZeneca
Figure Revenue and Market Share Analysis of AstraZeneca
Table Product and Service Introduction of AstraZeneca
Table Company Profile and Development Status of Bristol-Myers-Squibb
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers-Squibb
Figure Sales and Growth Rate Analysis of Bristol-Myers-Squibb
Figure Revenue and Market Share Analysis of Bristol-Myers-Squibb
Table Product and Service Introduction of Bristol-Myers-Squibb
Table Company Profile and Development Status of Novartis
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
Figure Sales and Growth Rate Analysis of Novartis
Figure Revenue and Market Share Analysis of Novartis
Table Product and Service Introduction of Novartis
Table Company Profile and Development Status of Gilead Sciences
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead Sciences
Figure Sales and Growth Rate Analysis of Gilead Sciences
Figure Revenue and Market Share Analysis of Gilead Sciences
Table Product and Service Introduction of Gilead Sciences
Table Company Profile and Development Status of Abbott
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott
Figure Sales and Growth Rate Analysis of Abbott
Figure Revenue and Market Share Analysis of Abbott
Table Product and Service Introduction of Abbott
Table Company Profile and Development Status of Gilead
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead
Figure Sales and Growth Rate Analysis of Gilead
Figure Revenue and Market Share Analysis of Gilead
Table Product and Service Introduction of Gilead
Table Company Profile and Development Status of GlaxoSmithKline & Co
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline & Co
Figure Sales and Growth Rate Analysis of GlaxoSmithKline & Co
Figure Revenue and Market Share Analysis of GlaxoSmithKline & Co
Table Product and Service Introduction of GlaxoSmithKline & Co
-
